Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services 2023-07-07 21:00
280 Bio receives IND approval from the FDA for YL-17231 2023-07-07 20:00
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs 2023-07-07 10:19
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment 2023-07-06 18:33
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development 2023-07-05 22:05
TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China 2023-07-05 20:00
I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC 2023-07-05 20:00
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China 2023-07-04 21:16
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy 2023-07-04 20:42
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration 2023-07-03 19:00
Henlius Forecasts Profit in 1H 2023 2023-07-03 17:49
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease 2023-07-03 08:00
Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally 2023-06-30 20:15
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA 2023-06-29 21:26
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial 2023-06-29 19:00
Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer 2023-06-29 16:31
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics 2023-06-28 20:58
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development 2023-06-28 20:00
Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite 2023-06-28 18:30
1 44 45 46 47 48 165